Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Previously Untreated Aggressive Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma
NCT00005964 is a phase 2 interventional trial sponsored by Alliance for Clinical Trials in Oncology. As of 21 Nov 2026, it is completed. It studies Cyclophosphamide, Doxorubicin, Etoposide, Filgrastim and 2 more drugs in Lymphoma. The registry lists an enrollment of 59 participants at 47 sites in 1 country. The registry lists a start date of 31 May 2000 and a primary completion date of 31 Mar 2006. One of its registered investigators has a FindMyKOL profile.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT00005964 |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional trial |
| Lead sponsor | Alliance for Clinical Trials in Oncology |
| Enrollment | 59 |
| Registered sites | 47 |
| Countries | 1 |
| Conditions | Lymphoma |
| Drugs | Cyclophosphamide, Doxorubicin, Etoposide, Filgrastim, Prednisone and Vincristine |
| Start | 31 May 2000 |
| Primary completion | 31 Mar 2006 |
| Study completion | 31 Mar 2006 |
| Last update posted | 13 Jul 2016 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
47 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Veterans Affairs Medical Center - Birmingham
Birmingham
- University of California San Diego Cancer Center
La Jolla
- Ucsf Cancer Center and Cancer Research Institute
San Francisco
- Veterans Affairs Medical Center - San Francisco
San Francisco
- Ccop - Christiana Care Health Services
Wilmington
- Lombardi Cancer Center
Washington D.C.
- Walter Reed Army Medical Center
Washington D.C.
- Ccop - Mount Sinai Medical Center
Miami Beach
- University of Chicago Cancer Research Center
Chicago
- Veterans Affairs Medical Center - Chicago (westside Hospital)
Chicago
- Holden Comprehensive Cancer Center at the University of Iowa
Iowa City
- Veterans Affairs Medical Center - Togus
Togus
- Marlene & Stewart Greenebaum Cancer Center, University of Maryland
Baltimore
- Dana-Farber Cancer Institute
Boston
- University of Massachusetts Memorial Medical Center
Worcester
- University of Minnesota Cancer Center
Minneapolis
- Veterans Affairs Medical Center - Minneapolis
Minneapolis
- Ellis Fischel Cancer Center - Columbia
Columbia
- Veterans Affairs Medical Center - Columbia (truman Memorial)
Columbia
- Barnes-Jewish Hospital
St Louis
- University of Nebraska Medical Center
Omaha
- Ccop - Southern Nevada Cancer Research Foundation
Las Vegas
- Norris Cotton Cancer Center
Lebanon
- Roswell Park Cancer Institute
Buffalo
- Veterans Affairs Medical Center - Buffalo
Buffalo
- Ccop - North Shore University Hospital
Manhasset
- North Shore University Hospital
Manhasset
- Memorial Sloan-Kettering Cancer Center
New York
- Mount Sinai Medical Center, Ny
New York
- New York Presbyterian Hospital - Cornell Campus
New York
- Ccop - Syracuse Hematology-Oncology Associates of Central New York, P.C.
Syracuse
- State University of New York - Upstate Medical University
Syracuse
- Veterans Affairs Medical Center - Syracuse
Syracuse
- Lineberger Comprehensive Cancer Center, Unc
Chapel Hill
- Duke Comprehensive Cancer Center
Durham
- Veterans Affairs Medical Center - Durham
Durham
- Ccop - Southeast Cancer Control Consortium
Winston-Salem
- Comprehensive Cancer Center at Wake Forest University
Winston-Salem
- Arthur G. James Cancer Hospital - Ohio State University
Columbus
- Rhode Island Hospital
Providence
- University of Tennessee, Memphis Cancer Center
Memphis
- Veterans Affairs Medical Center - Memphis
Memphis
- Ccop - Southwestern Vermont Regional Cancer Center
Bennington
- Vermont Cancer Center
Burlington
- Veterans Affairs Medical Center - White River Junction
White River Junction
- Mbccop - Massey Cancer Center
Richmond
- Veterans Affairs Medical Center - Richmond
Richmond
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Questions about NCT00005964
Each answer restates registry values shown on this page.
What is NCT00005964?
NCT00005964 is a phase 2 interventional trial sponsored by Alliance for Clinical Trials in Oncology. It studies Cyclophosphamide, Doxorubicin, Etoposide, Filgrastim and 2 more drugs in Lymphoma.
Who leads NCT00005964?
The registry names Andrew Zelenetz, MD, PhD (study chair, Memorial Sloan Kettering Cancer Center) as the overall official.
Where does NCT00005964 run?
The registry lists 47 sites in 1 country. Every site with a stated country is in one country: United States.
Which drugs does NCT00005964 study?
The registered drug and biological interventions are Cyclophosphamide, Doxorubicin, Etoposide, Filgrastim, Prednisone and Vincristine.
When did NCT00005964 end?
The registry lists a primary completion date of 31 Mar 2006 and a study completion date of 31 Mar 2006. The sponsor last updated the record on 13 Jul 2016.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.